Shifting Treatment Paradigms: Improvements in HR-Positive, HER-2- Negative Breast Cancer Care in Poland from a Clinical Perspective

por Ziobro, Marek, Grela-Wojewoda, Aleksandra
Publicado 2023

Microvessel Density and Status of p53 Protein as Potential Prognostic Factors for Adjuvant Anthracycline Chemotherapy in Retrospective Analysis of Early Breast Cancer Patients Grou...

por Biesaga, Beata, Niemiec, Joanna, Ziobro, Marek
Publicado 2012

BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy

por Biesaga, Beata, Niemiec, Joanna, Ziobro, Marek
Publicado 2014

Principles of prophylactic and therapeutic management of skin toxicity during treatment with checkpoint inhibitors

por Kamińska-Winciorek, Grażyna, Cybulska-Stopa, Bozena, Lugowska, Iwona, Ziobro, Marek, Rutkowski, Piotr
Publicado 2019

Evaluation of vinorelbine-based chemotherapy as the second or further-line treatment in patients with metastatic breast cancer

por Cybulska-Stopa, Bożena, Ziobro, Marek, Skoczek, Marta, Kojs-Pasińska, Ewelina, Cedrych, Ida, Brandys, Anna
Publicado 2013

Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV

por Cybulska-Stopa, Bożena, Skoczek, Marta, Ziobro, Marek, Świtaj, Tomasz, Falkowski, Sławomir, Morysiński, Tadeusz, Hetnał, Marcin, Cedrych, Ida, Rutkowski, Piotr
Publicado 2013

Early Effects of Nivolumab and Ipilimumab Combined Immunotherapy in the Treatment of Metastatic Melanoma in Poland: A Multicenter Experience

por Pacholczak-Madej, Renata, Grela-Wojewoda, Aleksandra, Puskulluoglu, Mirosława, Lompart, Joanna, Las-Jankowska, Manuela, Krawczak, Katarzyna, Wrona, Ewa, Zaręba, Lech, Żubrowska, Justyna, Walocha, Jerzy, Bazan-Socha, Stanisława, Ziobro, Marek
Publicado 2022

Low frequency of HPV positivity in breast tumors among patients from south-central Poland

por Biesaga, Beata, Janecka-Widła, Anna, Kołodziej-Rzepa, Marta, Mucha-Małecka, Anna, Słonina, Dorota, Ziobro, Marek, Wysocka, Joanna, Adamczyk, Agnieszka, Majchrzyk, Kaja, Niemiec, Joanna, Ambicka, Aleksandra, Grela-Wojewoda, Aleksandra, Harazin-Lechowska, Agnieszka
Publicado 2021

Biomarkers of Trastuzumab-Induced Cardiac Toxicity in HER2- Positive Breast Cancer Patient Population

por Grela-Wojewoda, Aleksandra, Püsküllüoğlu, Mirosława, Sas-Korczyńska, Beata, Zemełka, Tomasz, Pacholczak-Madej, Renata, Wysocki, Wojciech M., Wojewoda, Tomasz, Adamczyk, Agnieszka, Lompart, Joanna, Korman, Michał, Mucha-Małecka, Anna, Ziobro, Marek, Konduracka, Ewa
Publicado 2022

Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study

por Cybulska-Stopa, Bożena, Ługowska, Iwona, Jagodzińska-Mucha, Paulina, Koseła-Paterczyk, Hanna, Kozak, Katarzyna, Klimczak, Anna, Świtaj, Tomasz, Ziobro, Marek, Roman, Agnieszka, Rajczykowski, Marcin, Suwiński, Rafał, Niemiec, Maciej, Zemełka, Tomasz, Falkowski, Sławomir, Rutkowski, Piotr
Publicado 2019

Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma

por McDermott, David F., Lee, Jae-Lyun, Ziobro, Marek, Suarez, Cristina, Langiewicz, Przemyslaw, Matveev, Vsevolod Borisovich, Wiechno, Pawel, Gafanov, Rustem Airatovich, Tomczak, Piotr, Pouliot, Frederic, Donskov, Frede, Alekseev, Boris Yakovlevich, Shin, Sang Joon, Bjarnason, Georg A., Castellano, Daniel, Silverman, Rachel Kloss, Perini, Rodolfo F., Schloss, Charles, Atkins, Michael B.
Publicado 2021